Skip to main content

Advertisement

Table 1 Clinical data, BDI-II depression scores, imaging and histopathology data of the patients, who are listed in the order of decreasing BDI-II scores

From: Imaging cerebral tryptophan metabolism in brain tumor-associated depression

  Gender Age (years) BDI-II score New/rec Tumor type Grade Area max (cm2) Location Side
1 F 55 33 New Glioma 4 12.9 FP R
2 F 22 30 New Meningioma 2 8.5 F R
3 M 52 28 New Meningioma 1 12.2 Brainstem M
4 M 67 22 New Metastasis   1.8 F R
5 M 70 20 New Metastasis   17.7 TP L
6 M 63 17 Rec Glioma 2 43.6 FT R
7 M 48 14 New Glioma 3 25.3 F L
8 F 49 13 New Meningioma 1 9.6 F L
9 M 59 11 New Meningioma 1 4.6 Medulla M
10 F 37 9 New Glioma 2 11.8 F L
11 M 58 8 Rec Meningioma 2 8.7 P R
12 M 25 6 New Glioma 1 1 O R
13 M 46 6 Rec Glioma 4 2.6 PO, T R
14 F 60 6 New Metastasis   1.1 F L
15 F 84 5 New Meningioma 1 13.8 F L
16 F 70 5 New Glioma 4 1.6 T R
17 M 60 3 New Meningioma 1 13.2 Olfactory M
18 F 62 3 New Meningioma   6.2 FT L
19 M 68 3 New Meningioma   5.1 R lat clivus R
20 M 79 2 New Glioma 4 6.1 T L
21 M 68 2 New Meningioma 1 9.1 F L
  1. BDI-II Beck Depression Inventory-II, M male, F female, new/rec newly diagnosed/recurrent tumor, F frontal, T temporal, P parietal, O occipital, R right, L left, M midline, lat lateral